| Jacqueline Banasiewicz, LPC | |
|
45 S Main St, West Hartford, CT 06107-2441 | |
| (860) 414-4245 | |
| Not Available |
| Full Name | Jacqueline Banasiewicz |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 45 S Main St, West Hartford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013467133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 3023 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacqueline Banasiewicz, LPC 59 Wood Creek Rd, Burlington, CT 06013-1920 Ph: (860) 395-9857 | Jacqueline Banasiewicz, LPC 45 S Main St, West Hartford, CT 06107-2441 Ph: (860) 414-4245 |
News Archive
Transplanting previously frozen ovarian tissue back into female cancer survivors can lead to long-term hormonal function and preservation of fertility, according to a new study by Samuel Kim from the University of Kansas Medical Center in the US. His work-, which shows that hormonal function was restored in five women 12-20 weeks after transplantation, and in one case lasted for more than seven years, appears online in the Journal of Assisted Reproduction and Genetics-, published by Springer.
Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.
Ipsen today announced the initiation of an international, multi-center, controlled, randomized Phase II clinical trial to evaluate the safety and efficacy of BN83495, its investigational first-in-class steroid sulfatase (STS) inhibitor, in advanced endometrial cancer.
A new effort by the National Institutes of Health will facilitate communication among scientists, clinicians, and the public to reframe mental health research, from diagnosis to treatment. The Research Domain Criteria (RDoC) unit was recently established by the National Institute of Mental Health, part of NIH, to support the development of the institute's RDoC initiative.
Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.
› Verified 6 days ago
Meghan Dunn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 345 N Main St, West Hartford, CT 06117 Phone: 860-937-3875 | |
Dr. Julie B Saffir, PSY.D, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 17 S Highland St, West Hartford, CT 06119 Phone: 860-217-4240 | |
Mrs. Rachel Carlson, PSYD Counselor Medicare: Medicare Enrolled Practice Location: 17 S Highland St, West Hartford, CT 06119 Phone: 860-258-4171 | |
Mrs. Karen Elizabeth Brown, MED. LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 968 Farmington Ave, Suite 202, West Hartford, CT 06107 Phone: 860-523-0288 | |
Ms. Wendy Ellen Brus, MSW Counselor Medicare: Accepting Medicare Assignments Practice Location: 805 Farmington Ave, 2nd Floor, West Hartford, CT 06119 Phone: 860-232-2801 Fax: 860-232-2801 | |
Lisa Marie Ciorciari, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 17 S Highland St, West Hartford, CT 06119 Phone: 860-236-3649 |